ATTENTION: (NASDAQ) Pharma Stock Below $1 Announces Stem Cell Therapy CV-19 Related

ATTENTION: (NASDAQ) Pharma Stock Below $1

Announces Stem Cell Therapy CV-19 Related

April 3rd, 2020
StockStreetWire Member,

Grab yourself a coffee, and get yourself ready for your brand new NASDAQ stock profile coming this morning at approximately 9:00am EST.

This specialty pharma company is currently trading just under $1/share. Breaking news just made the headlines on April 1st, 2020 that they are racing to create a vaccine for the deadly silent killer CV-19.

Make sure you set up my SMS alert system so that you never miss a beat!

> SMS Set Up Instructions Below <

Step One: Go to your keypad on your cell phone and dial 40691

Step Two: Now go to "send message", type in "stockstreetwire" then select "send".

Stay tuned for more updates...

Regards,

Dan Davis

Editor

StockStreetWire

Disclosure: I am not a licensed financial adviser. All potential percentage gains are based on from the low to the high of day. StockStreetWire full disclosure is to be read and fully understood before using StockStreetWire website, or joining StockStreetWires' email or text list. By viewing StockStreetWire's website and/or reading StockStreetWire email or text newsletter you are agreeing to StockStreetWire's full disclosure which can be read at stockstreetwire.com/disclosure Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. Stock Wire News (stock wire news . com) is owned by Stock News Wire LLC, a limited liability company. A member of Stock News Wire, LLC owns an interest in the limited liability company that owns and operates stock street wire .com ("SSW"). From time to time, non-affiliated third parties hire Stock Wire News, or SSW jointly to publicly disseminate information about a company via website, email, SMS and other points of media.

1415 South Voss Rd
Houston TX 77057
USA

Leave a Reply Cancel reply